Smoking cessation pill Champix returns to market four years after withdrawal over carcinogen

Smoking cessation therapy varenicline tartrate (Champix; Pfizer) is now available again in the UK, having previously been withdrawn from the market, Pfizer has announced. Varenicline, a nicotine receptor partial agonist taken as a daily pill, is a prescription-only medicine for adults. In October 2021, Pfizer recalled Champix owing to the presence of unacceptable levels of […]

Publication Details

Journal: Pharmaceutical journal/The pharmaceutical journal
Published: 2025-01-01
DOI: https://doi.org/10.1211/pj.2025.1.362704
Primary Topic: Nutrition, Genetics, and Disease
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Smoking cessation pill Champix returns to market four years after withdrawal over carcinogen

Jan 1, 2025

Pharmaceutical journal/The pharmaceutical journal

Nutrition, Genetics, and Disease

article

Smoking cessation pill Champix returns to market four years after withdrawal over carcinogen

January 1, 2025article en

Abstract

Pharmaceutical journal/The pharmaceutical journal

Good health and well-being

Openalex Percentile: Top 82%

Nutrition, Genetics, and Disease

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Smoking cessation pill Champix returns to market four years after withdrawal over carcinogen · Pharmaceutical journal/The pharmaceutical journal (2025) | TGRS Research Map | TGRS